Dentsply Sirona (XRAY) Tops Q2 EPS by 6c, Offers FY Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.71, $0.06 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.01 billion.

GUIDANCE:

Dentsply Sirona sees FY2021 EPS of $2.75-$2.90, versus the consensus of $2.87. Dentsply Sirona sees FY2021 revenue of $4.1-4.3 billion, versus the consensus of $4.25 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance